Rt Hon JACINDA ARDERN: Again, the member is wrong in the premise of his question. We do still have supply from other vaccines. Those vaccines—AstraZeneca, Janssen, and others—continue to go through the Medsafe approval process. That process will only happen as quickly as those pharmaceutical companies provide the data that Medsafe requires. That's the first point I'll make. The second is that other countries who do have a mixed programme of vaccines—the likes of Australia—you'll notice have had to change up some of their direction around who is able to access that vaccine; it does not necessarily mean their roll-out is faster. The third point: all pharmaceutical companies have been ramping up their supply in the latter part of the calendar year of 2021; the first half of the year, for most vaccine suppliers, has always been constrained.